trending Market Intelligence /marketintelligence/en/news-insights/trending/NXS1hT2VuBAneQCr0-0Mew2 content esgSubNav
In This List

Report: Activist investor pushing for change at Alexion Pharmaceuticals

Blog

Banking Essentials Newsletter: 7th February Edition

Case Study

A Bank Outsources Data Gathering to Meet Basel III Regulations

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)

Blog

Essential IR Insights Newsletter Fall - 2023


Report: Activist investor pushing for change at Alexion Pharmaceuticals

Elliott Management Corp., a stakeholder in Alexion Pharmaceuticals Inc., is pushing the company to take measures aimed at raising its stock price, The New York Times reported Dec. 7, citing unnamed sources.

The U.S. hedge fund is urging Alexion to put out a more aggressive financial performance guidance or consider strategic options, including a sale of the company.

According to the publication's sources, Elliott Management could initiate a proxy fight to take board seats if the biopharmaceutical company fails to take action.

Following the report, Alexion's stock was up 8.37% to $115.72 as of 2:22 p.m. ET on Dec. 8.